Micrazym

Pancreatin, the active ingredient in Micrazym, is a digestive enzyme presented as an oral formulation for oral use. It supplies the pancreatic enzymes that are deficient in conditions such as exocrine pancreatic insufficiency, helping to hydrolyze proteins, fats, and carbohydrates for improved nutrient absorption.

GNH USA supplies Micrazym as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution, ensuring product integrity across markets.

Micrazym, containing pancreatin, is used in the management of disorders characterized by pancreatic enzyme deficiency. - Exocrine pancreatic insufficiency: Improves digestion and nutrient absorption by supplying missing enzymes. - Cystic fibrosis‑related pancreatic insufficiency: Reduces gastrointestinal symptoms and supports growth. - Chronic pancreatitis: Alleviates malabsorption and steatorrhea associated with reduced pancreatic output. - Post‑pancreatectomy patients: Assists in digestion after surgical removal of pancreatic tissue.

Pancreatin may cause a range of adverse reactions, most of which are mild and related to gastrointestinal tolerance.

Common Side Effects: - Abdominal discomfort: mild pain or cramping in the stomach area. - Flatulence: increased gas production leading to bloating. - Diarrhea: loose stools occurring after dosing. - Nausea: feeling of sickness or urge to vomit.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis in susceptible individuals. - Severe abdominal pain: may indicate pancreatitis exacerbation. - Intestinal obstruction: blockage symptoms such as vomiting and inability to pass gas.

When prescribing Micrazym, clinicians should consider several precautionary measures to ensure safe and effective use. - Assess pancreatic function: confirm enzyme deficiency before initiating therapy. - Monitor for allergic reactions: discontinue if signs of hypersensitivity appear. - Adjust dose based on clinical response: titrate to achieve symptom control. - Avoid use in patients with known hypersensitivity to porcine‑derived products: pancreatin is typically derived from pig pancreas. - Caution in patients with ulcerative colitis or inflammatory bowel disease: may exacerbate symptoms. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Pancreatin can interact with certain medications, affecting its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: neutralize gastric acidity and reduce enzyme activity. - Cholestyramine or other bile acid sequestrants: bind pancreatic enzymes and diminish absorption.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may alter gastric pH, potentially affecting enzyme activation; monitor therapeutic response. - Oral contraceptives: rare reports of altered hormone levels; observe for any changes. - Antibiotics such as tetracycline: may cause gastrointestinal upset when combined; assess tolerability.